The SLC22 family, such as SLC22A18, acts as a tumor suppressor in ovarian cancer, with downregulation correlating with reduced survival (78), and suppresses tumor growth in colorectal cancer when downregulated (80, 82, 83). This evidence concerns the gene SLC67A1 and neoplasm.